A DRUG that President Donald Trump praised for treating coronavirus was approved by the U.S. Food and Drug Administration, marking the second breakthrough on Monday around fighting the disease.
The FDA’s emergency use authorization makes Eli Lilly and Co's experimental Covid-19 antibody treatment available for patients with mild to moderate symptoms who are not hospitalized and are over 65 years old or have chronic medical conditions.
Eli Lilly and Co’s antibody may also be used on pediatric patients over 12 years old, but is not authorized for coronavirus patients in hospitals or those needing oxygen therapy.
The government sponsored a study using the antibody on hospitalized coronavirus patients but halted it after their condition did not appear to improve.
Source: Read Full Article